Collegium Pharmaceutical (COLL) Shares Repurchased (2021 - 2024)
Historic Shares Repurchased for Collegium Pharmaceutical (COLL) over the last 4 years, with Q4 2024 value amounting to $25.0 million.
- Collegium Pharmaceutical's Shares Repurchased rose 10.0% to $25.0 million in Q4 2024 from the same period last year, while for Sep 2025 it was $50.0 million, marking a year-over-year decrease of 2301.24%. This contributed to the annual value of $60.0 million for FY2024, which is 1996.67% down from last year.
- Latest data reveals that Collegium Pharmaceutical reported Shares Repurchased of $25.0 million as of Q4 2024, which was up 10.0% from $25.0 million recorded in Q4 2023.
- Over the past 5 years, Collegium Pharmaceutical's Shares Repurchased peaked at $32.3 million during Q4 2021, and registered a low of $7.6 million during Q4 2022.
- Moreover, its 4-year median value for Shares Repurchased was $25.0 million (2023), whereas its average is $22.5 million.
- As far as peak fluctuations go, Collegium Pharmaceutical's Shares Repurchased tumbled by 7637.07% in 2022, and later soared by 22718.23% in 2023.
- Over the past 4 years, Collegium Pharmaceutical's Shares Repurchased (Quarter) stood at $32.3 million in 2021, then tumbled by 76.37% to $7.6 million in 2022, then skyrocketed by 227.18% to $25.0 million in 2023, then increased by 0.1% to $25.0 million in 2024.
- Its Shares Repurchased stands at $25.0 million for Q4 2024, versus $25.0 million for Q4 2023 and $7.6 million for Q4 2022.